Titre du document / Document title
Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs
Auteur(s) / Author(s)
QING YANG
(1) ;
QIN HU
(1) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Department of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, CHINE
Résumé / Abstract
The pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs were investigated. Blood concentrations of acyclovir were determined by RP-HPLC after a single oral dose of two kinds of acyclovir tablets given separately to 6 beagle dogs. The main pharmacokinetics parameters of the acyclovir sustained-release tablet were as follows: T
1/2, T
max and C
max were 4.10±0.20 h, 4.05±0.54 h and 6.90±0.68 μg·ml
-1, respectively. MRT was 9.02±0.44 h. Using acyclovir standard tablet as control, relative bioavailability of the acyclovir sustained-release tablet was 152.2±49.90 %. According to the two-tailed t-test, there was a distinct difference in the data for T
max, C
max and AUC between acyclovir sustained-release tablets and acyclovir standard tablets, and the absorbability of acyclovir sustained-release tablets was much better than that of the acyclovir standard tablets.
Revue / Journal Title
European journal of drug metabolism and pharmacokinetics
ISSN 0378-7966
Source / Source
2006, vol. 31, n
o1, pp. 17-20 [4 page(s) (article)] (4 ref.)
Langue / Language
Anglais
Editeur / Publisher
Médecine et hygiène, Genève, SUISSE
(1976)
(Revue)
Mots-clés anglais / English Keywords
Dosage form ;
Nucleoside analog ;
Purine nucleoside ;
Acyclic nucleoside ;
Vertebrata ;
Mammalia ;
Carnivora ;
Fissipedia ;
HPLC chromatography ;
Dog ;
Animal ;
Tablet ;
Controlled release form ;
Antiviral ;
Aciclovir ;
Bioavailability ;
Pharmacokinetics ;
Mots-clés français / French Keywords
Forme pharmaceutique ;
Analogue nucléoside ;
Purine nucléoside ;
Nucléoside acyclique ;
Vertebrata ;
Mammalia ;
Carnivora ;
Fissipedia ;
Chromatographie HPLC ;
Chien ;
Animal ;
Comprimé ;
Forme libération contrôlée ;
Antiviral ;
Aciclovir ;
Biodisponibilité ;
Pharmacocinétique ;
Mots-clés espagnols / Spanish Keywords
Forma farmacéutica ;
Análogo nucleósido ;
Purina nucleósido ;
Nucleósido acíclico ;
Vertebrata ;
Mammalia ;
Carnivora ;
Fissipedia ;
Cromatografía HPLC ;
Perro ;
Animal ;
Tableta ;
Forma liberación controlada ;
Antiviral ;
Aciclovir ;
Biodisponibilidad ;
Farmacocinética ;
Mots-clés d'auteur / Author Keywords
Acyclovir ;
pharmacokinetics ;
bioavailability ;
HPLC ;
Localisation / Location
INIST-CNRS, Cote INIST : 16876, 35400014268776.0040
Nº notice refdoc (ud4) : 17718044